Bicara Therapeutics Inc. (BCAX) has 9 open-market insider trades by 7 insiders since 2024. The most active filer is Claire Mazumdar, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| RA Capital Nexus Fund III, L.P. | Dir10% Owner | — | 1 | $33.0M | 2024-09-16 |
| RA Capital Management, L.P. | Dir10% | — | 1 | $4.8M | 2026-02-26 |
| Claire Mazumdar | CEO | — | 2 | $859K | 2026-08-10 |
| Deerfield Private Design Fund V, L.P. | 10% Owner | — | 1 | $630K | 2024-09-17 |
| Ivan Hyep | CFO | — | 2 | $335K | 2026-08-10 |
| Ryan Cohlhepp | CEOPresCOO | — | 1 | $316K | 2026-09-08 |
| David Raben | — | — | 1 | $306K | 2026-04-27 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ryan Cohlhepp | CEO & President +1 | Sell | $401K | 2026-09-08 |
| Ryan Cohlhepp | President & COO | Sell | $525K | 2026-08-10 |
| Ivan Hyep | CFO | Sell | $350K | 2026-08-10 |
| Claire Mazumdar | CEO | Sell | $280K | 2026-08-10 |
| Claire Mazumdar | CEO | Sell | $284K | 2026-07-10 |
| Ivan Hyep | CFO | Sell | $808K | 2026-07-08 |
Companies that share insiders with BCAX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Ryan Cohlhepp | President & COO | Sell | $833K | 2026-07-08 |
| Ivan Hyep | CFO | Sell | $188K | 2026-05-21 |
| Claire Mazumdar | CEO | Sell | $301K | 2026-05-18 |
| Ryan Cohlhepp | President & COO | Sell | $254K | 2026-05-15 |
| David Raben | — | Sell | $126K | 2026-04-27 |
| Ivan Hyep | CFO | Sell | $212K | 2026-04-21 |
| Claire Mazumdar | CEO | Sell | $354K | 2026-04-20 |
| Ryan Cohlhepp | President & COO | Sell | $288K | 2026-04-15 |
| David Raben | — | Sell | $208K | 2026-03-25 |